Pfizer Inc (NYSE:PFE) is a trending stock, with analysts predicting a rally in major healthcare stocks like Pfizer. The company recently announced plans to acquire Metsera, Inc. (NASDAQ: MTSR), focusing on obesity and cardiometabolic diseases. PFE is down about 1% this year, despite positive developments.

Investment firm Parnassus Investments recently released its investor letter, revealing they exited their position in Pfizer Inc (NYSE:PFE) due to reduced conviction in its turnaround thesis. The firm cited a weaker research and development pipeline and potential merger and acquisition activities as reasons for the decision.

While Pfizer Inc (NYSE:PFE) offers potential as an investment, some believe that certain AI stocks hold greater promise with limited downside risk. Investors looking for cheap AI stocks with high return potential should consider other options. Check out our free report on the best short-term AI stock for more information.

Read more at Yahoo Finance: Should You Buy Pfizer (PFE) Before a Breakout Begins?